An Enhanced Hemostatic Factor VIII Variant for Hemophilia A Gene Therapy

被引：0
|
作者：
Sternberg, Anna R. [1 ,2 ]
Davidson, Robert J. [1 ]
Wilhelm, Amelia R. [1 ]
George, Lindsey A. [1 ,2 ]
机构：
[1] CHOP, Philadelphia, PA USA
[2] UPENN, Philadelphia, PA USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
697
引用
收藏
页码：328 / 329
页数：2
相关论文
共 50 条
  • [31] A Novel Factor VIII Variant That Yields Improved Secretion and Reduced ER Stress for Second Generation AAV-Mediated Gene Therapy for Hemophilia A
    Lindgren, Jonathan R.
    Seleme, Marie
    Henriksen, Allysen
    Nguyen, Giang N.
    Sabatino, Denise E.
    MOLECULAR THERAPY, 2024, 32 (04) : 520 - 520
  • [32] Creating a DDAVP Releasable Pool of Factor VIII: Its Impact on the Gene Therapy of Hemophilia A † 786
    Robert R Montgomery
    Janet L Endres
    Jonathan B Rosenberg
    J Paul Scott
    Joan Cox Gill
    Pediatric Research, 1998, 43 (Suppl 4) : 136 - 136
  • [33] Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A
    Evans, GL
    Chuah, MKL
    VandenDriessche, T
    Morgan, RA
    BLOOD, 1995, 86 (10) : 3976 - 3976
  • [34] High Expression Bioengineered Factor VIII Enables AAV-Based Gene Therapy of Hemophilia A
    Spencer, H. Trent
    Brown, Harrison C.
    Shields, Jordan E.
    Wright, J. Fraser
    Doering, Christopher B.
    MOLECULAR THERAPY, 2013, 21 : S253 - S253
  • [35] GENE THERAPY TARGETING SYNTHESIS OF COAGULATION FACTOR VIII IN PLATELETS REDUCES BLEEDING IN CANINE HEMOPHILIA A
    Du, L. M.
    Franck, H. W. G.
    Merricks, E. P.
    Nurden, P.
    Jensen, E. S.
    Haberichter, S. L.
    Hawkins, T. B.
    Jacobi, P. M.
    Fang, J.
    Nichols, T. C.
    Koukouritaki, S. B.
    Shi, Q.
    Nurden, A. T.
    Montogomery, R. R.
    Cornetta, K.
    Wilcox, D. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S149 - S150
  • [36] Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
    George, L. A.
    Sullivan, S. K.
    Giermasz, A.
    Rasko, J. E. J.
    Samelson-Jones, B. J.
    Ducore, J.
    Cuker, A.
    Sullivan, L. M.
    Majumdar, S.
    Teitel, J.
    McGuinn, C. E.
    Ragni, M. V.
    Luk, A. Y.
    Hui, D.
    Wright, J. F.
    Chen, Y.
    Liu, Y.
    Wachtel, K.
    Winters, A.
    Tiefenbacher, S.
    Arruda, V. R.
    van der Loo, J. C. M.
    Zelenaia, O.
    Takefman, D.
    Carr, M. E.
    Couto, L. B.
    Anguela, X. M.
    High, K. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (23): : 2215 - 2227
  • [37] Inversions of the factor VIII gene in Japanese patients with severe hemophilia A
    Fukuda, K
    Naka, H
    Morichika, S
    Shibata, M
    Tanaka, I
    Shima, M
    Yoshioka, A
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (03) : 303 - 306
  • [38] Ministring DNA Encoding Human Factor VIII Gene: A Novel Paradigm of Nonviral Gene Therapy for Hemophilia A Patients
    Chao, Ting-Yen
    Fan, Meng-Ni
    Currie, Ko
    Cai, Xiaohe
    Xu, Yuanyi
    Slavcev, Roderick
    Nafissi, Nafiseh
    Miao, Carol H.
    MOLECULAR THERAPY, 2023, 31 (04) : 415 - 416
  • [39] Evolution Directed Gene Engineering (EDGE) Identifies Factor VIII Variants Augmented for Gene Therapy in Hemophilia A Mice
    Suber, Yani
    Van Gorder, Lucas
    Chau, Julia
    Lee, Kyumin
    Peng, Riley
    Samelson-Jones, Benjamin
    MOLECULAR THERAPY, 2024, 32 (04) : 774 - 775
  • [40] THE FACTOR-VIII GENE AND THE MOLECULAR-GENETICS OF HEMOPHILIA
    LAWN, RM
    CHEMICA SCRIPTA, 1986, 26B : 237 - 240
12345